✦ LIBER ✦

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients with Symptomatic Heart Failure and Systolic Dysfunction: The ECLIPSE International, Multicenter, Randomized, Placebo-controlled Trial

✍ Scribed by James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimmer; Geir Frivold; W. Herbert Haught; Sheba Meymandi; Patricia Wedge; Marvin M. Konstam; Mihai Gheorghiade

Book ID: 119214599
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 96 KB
Volume: 13
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2007.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute Hemodynamic Effects of Tolvaptan,

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction: An International, Multicenter, Randomized, Placebo-Controlled Trial

✍ James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimme 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 561 KB

A Multicenter, Randomized, Double-blind,

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

✍ James E. Udelson; Martin Bilsker; Paul J. Hauptman; Rafael Sequeira; Ignatius Th 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Multicenter, Randomized, Double-Blind, P

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction

✍ James E. Udelson; Frank A. McGrew; Enrique Flores; Hassan Ibrahim; Stewart Katz; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 519 KB